Impact of product safety changes on accidental exposures to liquid laundry packets in children

Kate M Reynolds1, Randy I Burnham1, Heather Delva-Clark1

  • 1Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO, USA.

Insights

The ASTM International safety standard significantly reduced accidental liquid laundry packet (LLP) exposures in children. This led to fewer healthcare visits and severe outcomes, demonstrating the standard's effectiveness in child safety.

Area of Science:

  • Public Health
  • Consumer Product Safety
  • Pediatric Toxicology

Background:

  • Accidental exposures to liquid laundry packets (LLPs) in children pose a significant public health risk.
  • Prior to 2014, there was a need for standardized safety measures to mitigate these incidents.

Purpose of the Study:

  • To assess the impact of the ASTM International safety standard on accidental pediatric exposures to LLPs.
  • To evaluate changes in the severity and healthcare utilization associated with LLP exposures post-standard implementation.

Main Methods:

  • Utilized the National Poison Data System to analyze 73,942 accidental LLP exposures in children under 6 years old (July 2012-December 2018).
  • Categorized exposures into baseline, transition, and post-standard periods, correlating with voluntary product changes (2013-2016).
  • Compared exposure counts and sales-adjusted rates between baseline and post-periods, focusing on healthcare facility evaluations, admissions, and major medical outcomes.

Main Results:

  • Total accidental exposures decreased significantly, with sales-adjusted rates dropping by 57.4%.
  • Healthcare facility evaluations decreased by 65.0%, admissions by 81.4%, and major medical outcomes by 90.9% post-standard.
  • The percentage of exposures requiring healthcare facility evaluation, admission, or resulting in major medical outcomes saw a marked reduction.

Conclusions:

  • The implementation of the ASTM International safety standard was associated with a substantial decrease in the morbidity of accidental LLP exposures in children.
  • Further ongoing monitoring is recommended to ensure continued safety and identify any need for additional protective measures.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
166
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
135
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.0K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.6K